Access Campaign

CHA

Tag: Access Campaign

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...

Read more

Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine

Geneva, 21 January 2020 — As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) stressed that more must be done to...

Read more

MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumonia vaccine

New Delhi - Ahead of this week’s board meeting of Gavi, the Vaccine Alliance, in New Delhi, India, Doctors without Borders/Médecins Sans Frontières (MSF) called on board members to immediately stop paying out funds from a remaining US$262 million subsidy...

Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more

MSF urges PM Modi not to make any trade commitments to US threatening access to medicines

Ahead of the Prime Minister Narendra Modi’s visit to the US to discuss a ‘trade-package’ with the US President Donald Trump, Médecins Sans Frontières/ Doctors Without Borders (MSF) urges the Indian government to not make any commitments regarding intellectual property,...

Read more

Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV

Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection. Delhi/Geneva - Pharmaceutical corporation Gilead Sciences has failed to deliver on promises to make...

Read more

MSF: U.S. Special 301 report undermines efforts to lower medicine prices globally

On the eve of World Intellectual Property Day, the United States Trade Representative released its annual “Special 301 Report.” Developing countries like India and Malaysia once again face unfair pressure from the US government over the measures these countries have...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Read more

Access to medicines

Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...

Read more

Access Campaign

MSF in India: Projects in IndiaAccess campaign Connect with us MSF strengthening commitment to access to products for healthcare New structure will continue vital work to improve access to products for healthcare for people who need them most.Driven by a...

Read more

ASEAN and India urged not to trade away people’s lives in trade agreement

RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons